TY - JOUR
T1 - Toxic and nontoxic changes induced in the urothelium by xenobiotics
AU - Cohen, Samuel M.
N1 - Funding Information:
I gratefully acknowledge the advice and comments of Drs. Emily Garland and Tsuneo Masui, Drs. Charles Frith and Tomoyuki Shirai for contributing some of the photographs, and Jan Leemkuil for her assistance in the preparation of this manuscript. The research reported has been supported in part by USPHS Grants CA325 13 and CA36727 from the National Cancer Institute and by a grant from the International Life Sciences Institute-Nutrition Foundation.
PY - 1989/12
Y1 - 1989/12
N2 - Urothelial carcinogenesis progresses through several morphologically identifiable stages from simple hyperplasia, to nodular and papillary hyperplasia, to papilloma, and to noninvasive and invasive carcinoma. Unfortunately, no specific identifiable markers on any of the early lesions are available to distinguish those which will become neoplasms from those that are potentially reversible. Urothelial toxicity secondary to cyclophosphamide injection also progresses through several phases, beginning with vacuolization of the epithelium, to necrosis and ulceration, followed by an inflammatory infiltrate, granulation tissue formation, and marked regenerative hyperplasia of the epithelium, with ultimate repair and return to normal. Numerous changes related to toxicity are similar to those seen during carcinogenesis. In addition, several apparent morphologic "changes" occurring in the adult bladder can be mistaken for evidence of toxicity, and more importantly, many of the changes seen during regenerative repair and during carcinogenesis occur in the normal fetal urothelial development.
AB - Urothelial carcinogenesis progresses through several morphologically identifiable stages from simple hyperplasia, to nodular and papillary hyperplasia, to papilloma, and to noninvasive and invasive carcinoma. Unfortunately, no specific identifiable markers on any of the early lesions are available to distinguish those which will become neoplasms from those that are potentially reversible. Urothelial toxicity secondary to cyclophosphamide injection also progresses through several phases, beginning with vacuolization of the epithelium, to necrosis and ulceration, followed by an inflammatory infiltrate, granulation tissue formation, and marked regenerative hyperplasia of the epithelium, with ultimate repair and return to normal. Numerous changes related to toxicity are similar to those seen during carcinogenesis. In addition, several apparent morphologic "changes" occurring in the adult bladder can be mistaken for evidence of toxicity, and more importantly, many of the changes seen during regenerative repair and during carcinogenesis occur in the normal fetal urothelial development.
UR - http://www.scopus.com/inward/record.url?scp=0024797836&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024797836&partnerID=8YFLogxK
U2 - 10.1016/0041-008X(89)90197-X
DO - 10.1016/0041-008X(89)90197-X
M3 - Article
C2 - 2603162
AN - SCOPUS:0024797836
SN - 0041-008X
VL - 101
SP - 484
EP - 498
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 3
ER -